Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
2-Arylpyrazolo[4,3-d]pyrimidin-7-amino derivatives as new potent and selective human A3 adenosine receptor antagonists. Molecular modeling studies and pharmacological evaluation.
Squarcialupi L, Colotta V, Catarzi D, Varano F, Filacchioni G, Varani K, Corciulo C, Vincenzi F, Borea PA, Ghelardini C, Di Cesare Mannelli L, Ciancetta A, Moro S. Squarcialupi L, et al. J Med Chem. 2013 Mar 28;56(6):2256-69. doi: 10.1021/jm400068e. Epub 2013 Mar 7. J Med Chem. 2013. PMID: 23427825
Pyrazolo[1,5-c]quinazoline derivatives and their simplified analogues as adenosine receptor antagonists: synthesis, structure-affinity relationships and molecular modeling studies.
Catarzi D, Colotta V, Varano F, Poli D, Squarcialupi L, Filacchioni G, Varani K, Vincenzi F, Borea PA, Dal Ben D, Lambertucci C, Cristalli G. Catarzi D, et al. Bioorg Med Chem. 2013 Jan 1;21(1):283-94. doi: 10.1016/j.bmc.2012.10.031. Epub 2012 Oct 29. Bioorg Med Chem. 2013. PMID: 23171656
Pharmacological characterization of some selected 4,5-dihydro-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates and 3-hydroxyquinazoline-2,4-diones as (S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)-propionic acid receptor antagonists.
Catarzi D, Lenzi O, Colotta V, Varano F, Poli D, Filacchioni G, Lingenhöhl K, Ofner S. Catarzi D, et al. Chem Pharm Bull (Tokyo). 2010 Jul;58(7):908-11. doi: 10.1248/cpb.58.908. Chem Pharm Bull (Tokyo). 2010. PMID: 20606335 Free article.
Pyrido[2,3-e]-1,2,4-triazolo[4,3-a]pyrazin-1-one as a new scaffold to develop potent and selective human A3 adenosine receptor antagonists. Synthesis, pharmacological evaluation, and ligand-receptor modeling studies.
Colotta V, Lenzi O, Catarzi D, Varano F, Filacchioni G, Martini C, Trincavelli L, Ciampi O, Pugliese AM, Traini C, Pedata F, Morizzo E, Moro S. Colotta V, et al. J Med Chem. 2009 Apr 23;52(8):2407-19. doi: 10.1021/jm8014876. J Med Chem. 2009. PMID: 19301821
Novel potent and highly selective human A(3) adenosine receptor antagonists belonging to the 4-amido-2-arylpyrazolo[3,4-c]quinoline series: molecular docking analysis and pharmacological studies.
Colotta V, Capelli F, Lenzi O, Catarzi D, Varano F, Poli D, Vincenzi F, Varani K, Borea PA, Dal Ben D, Volpini R, Cristalli G, Filacchioni G. Colotta V, et al. Bioorg Med Chem. 2009 Jan 1;17(1):401-10. doi: 10.1016/j.bmc.2008.10.018. Epub 2008 Oct 11. Bioorg Med Chem. 2009. PMID: 18996701
Synthesis and biological evaluation of novel 9-heteroaryl substituted 7-chloro-4,5-dihydro-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates (TQX) as (R,S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid (AMPA) receptor antagonists.
Catarzi D, Colotta V, Varano F, Filacchioni G, Gratteri P, Sgrignani J, Galli A, Costagli C. Catarzi D, et al. Chem Pharm Bull (Tokyo). 2008 Aug;56(8):1085-91. doi: 10.1248/cpb.56.1085. Chem Pharm Bull (Tokyo). 2008. PMID: 18670107 Free article.
90 results